Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.AuthorsLee, Hans C.; Shah, Jatin J.; Feng, Lei; Manasanch, Elisabet E.; Lu, Rebecca; Morphey, Ashley; Crumpton, Brandon; Patel, Krina K.; Wang, Michael L.; Alexanian, Raymond; Thomas, Sheeba K.; Weber, Donna M.; Orlowski, Robert Z.SubjectsDEXAMETHASONE; MULTIPLE myeloma treatment; PROTEASOME inhibitors; KINESIN; DRUG administrationPublicationBlood Cancer Journal, 2019, Vol 9, Issue 10, pN.PAGISSN2044-5385Publication typeLetterDOI10.1038/s41408-019-0240-6